QCG
ADPT icon

Quadrant Capital Group’s Adaptive Biotechnologies ADPT Stock Holding History

Quadrant Capital Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,396
Closed -$117K – 1264
2026
Q1 		$117K Hold
8,396
– – ﹤0.01% 1440
2025
Q4 		$136K Sell
8,396
-480
-5% -$7.83K ﹤0.01% 1405
2025
Q3 		$133K Buy
+8,876
New +$108K ﹤0.01% 1403
2025
Q2 		– Sell
-9,635
Closed -$71.6K – 1352
2025
Q1 		$71.6K Buy
9,635
+759
+9% +$5.83K ﹤0.01% 1611
2024
Q4 		$53.2K Hold
8,876
– – ﹤0.01% 1378
2024
Q3 		$45.4K Hold
8,876
– – ﹤0.01% 1498
2024
Q2 		$32.1K Buy
8,876
+8,287
+1,407% +$26.3K ﹤0.01% 1638
2024
Q1 		$1.89K Buy
+589
New +$2.28K ﹤0.01% 2523
2023
Q4 		– Sell
-125
Closed -$682 – 2694
2023
Q3 		$682 Sell
125
-1,090
-90% -$7.21K ﹤0.01% 2530
2023
Q2 		$8.15K Sell
1,215
-343
-22% -$2.55K ﹤0.01% 2076
2023
Q1 		$13.8K Buy
1,558
+192
+14% +$1.69K ﹤0.01% 1880
2022
Q4 		$10.4K Buy
1,366
+201
+17% +$1.56K ﹤0.01% 1927
2022
Q3 		$8K Sell
1,165
-38
-3% -$358 ﹤0.01% 1948
2022
Q2 		$10K Buy
1,203
+432
+56% +$3.8K ﹤0.01% 1635
2022
Q1 		$10K Buy
+771
New +$12.1K ﹤0.01% 1625
2021
Q4 		– Sell
-7
Closed – – 2485
2021
Q3 		$0 Buy
+7
New +$253 ﹤0.01% 2479
2021
Q2 		– Sell
-5
Closed – – 2392
2021
Q1 		$0 Buy
5
+2
+67% +$108 ﹤0.01% 2374
2020
Q4 		$0 Buy
+3
New +$155 ﹤0.01% 2280

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quadrant Capital Group's ADPT Position: Q2 2026 in Review

Quadrant Capital Group sold out of Adaptive Biotechnologies (ADPT) in Q2 2026, closing a stake of 8,396 shares — an estimated $117K sold.

Quadrant Capital Group first reported a position in ADPT in Q4 2020 and held it in 18 quarters. The position peaked at $136K in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Quadrant Capital Group reported no remaining Adaptive Biotechnologies position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 8,396 Adaptive Biotechnologies shares in Q2 2026, an estimated $117K.
  • Quadrant Capital Group first reported a position in Adaptive Biotechnologies in Q4 2020 and held it in 18 quarters.
  • Quadrant Capital Group's Adaptive Biotechnologies position peaked at $136K in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.